लोड हो रहा है...
Study Sets Response Benchmarks for FLT3‐Inhibitor Sequencing in FLT3‐Mutated AML
A new study of sequential exposure to FLT3 inhibitors demonstrates the benefits of these therapies across multiple lines and treatment settings for patients with FLT3‐mutated acute myeloid leukemia.
में बचाया:
| में प्रकाशित: | Oncologist |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley & Sons, Inc.
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7869113/ https://ncbi.nlm.nih.gov/pubmed/33368881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13648 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|